Arcturus Therapeutics Holdings, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-80.00
-27.00
11.00
-204.00
-71.00
-25.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-20.00
7.00
-12.00
31.00
21.00
15.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-59.00
-18.00
31.00
-135.00
-42.00
-6.00
Cash Flow from Investing Activities
0.00
-2.00
-7.00
-3.00
-1.00
0.00
Cash Flow from Financing Activities
5.00
-24.00
-2.00
48.00
436.00
41.00
Net Cash Inflow / Outflow
-54.00
-45.00
21.00
-90.00
391.00
34.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Arcturus Therapeutics Holdings, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-80.9450000001537
-241.599
161.00
66.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-20.8090000000395
-32.674
12.00
36.31%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-59.7470000001134
-158.564
99.00
62.32%
Cash Flow from Investing Activities
-0.64800000000123
-62.848
62.00
98.97%
Cash Flow from Financing Activities
5.41800000001029
659.507
-654.00
-99.18%
Net Cash Inflow / Outflow
-54.9770000001044
431.293
-485.00
-112.75%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-6.802
6.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -230.11% vs -156.57% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-59.75
-18.10
-230.11%






